This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jul 22, 2026
•
1 min read
The update expands access to MiniMed's latest pump, with its sensor portfolio, helping reduce the day to day burden of diabetes for adults living with diabetes.
Jul 13, 2026
Canadian adults, 18 years and older, with diabetes will have access to Dexcom's sensor with the longest wear time, setting a new standard for the company.
Jul 6, 2026
Spain is the latest European market that now has access to Omnipod 5 and Insulet products, with more planned to come later this year.
Jun 23, 2026
The new sensor availability gives European markets access to the most current MiniMed automated insulin delivery and Smart multiple daily injections systems.
Jun 15, 2026
Dexcom's over-the-counter Stelo sensor is now available for adults and children who are not taking insulin to help improve glycemic awareness.
Jun 9, 2026
Dexcom released data at ADA 2026 showing Dexcom G7 improves glucose levels for people with type 2 diabetes compared to those using traditional blood glucose tests.
Jun 4, 2026
CeQur Simplicity wearable insulin patch is now approved for extended wear-time plus a new version with one unit dosing to help ease precision
Jun 3, 2026
Insulet is bringing a new target glucose of 100 mg/dL to Omnipod 5 to improve time in range and upgrades to increase time in automated mode.
Jun 2, 2026
Dexcom's Customer Advisory Council Report reveals user feedback and problems the the company has begun tackling to regain trust within the community.
Jun 1, 2026
The twiist insiights app updates come on the heels of several new twiist updates including alerts for followers, snooze options, sleep schedules, and more.
May 29, 2026
Afrezza, the only inhalable mealtime insulin, is now available to children and adolescents signifying a step forward in pediatric diabetes care
May 27, 2026
An estimated 7 million pods fall within the scope of this correction, in the U.S. and international markets, representing about 8.5% of 2025 global Pod production.
Abbott's new Libre Duo sensors measure ketones and glucose levels simultaneously, and will be available in select European countries in late-2026.
May 14, 2026
Dexcom’s next-gen G8 CGM is 50% smaller than the G7, last 15 days, and use self-adapting tech designed to improve accuracy. The company also teased future multi-analyte monitoring for potassium and ketones.
May 12, 2026
With CE Mark approval, Diabeloop's DBLG2 now integrates with the Kaleido pump and Dexcom G7.
